Skip to main content
Top

Journal of Endocrinological Investigation

Issue 11/2022

Content (20 Articles)

Open Access Autism Spectrum Disorder Original Article

Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment

F. Mazzoli, E. Cassioli, J. Ristori, G. Castellini, E. Rossi, C. Cocchetti, A. Romani, T. Angotti, G. Giovanardi, M. Mosconi, V. Lingiardi, A. M. Speranza, V. Ricca, L. Vignozzi, M. Maggi, A. D. Fisher

Open Access Original Article

Vitamin D status and parathyroid hormone assessment in girls with central precocious puberty

T. Durá-Travé, F. Gallinas-Victoriano

Open Access Obesity Original Article

Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity

P. Fierabracci, A. Basolo, G. Scartabelli, S. Bechi Genzano, G. Salvetti, G. Sotgia, M. Rotondi, L. Chiovato, G. Ceccarini, F. Santini

Original Article

Leptin, ghrelin, nesfatin-1, and orexin-A plasma levels in girls with premature thelarche

N. Almasi, H. Y. Zengin, N. Koç, S. A. Uçakturk, D. İskender Mazman, N. Heidarzadeh Rad, M. Fisunoglu

Open Access Insulins Original Article

Maternal body mass index and placental weight: a role for fetal insulin, maternal insulin and leptin

O. Kristiansen, M. C. Roland, M. Zucknick, T. M. Reine, S. O. Kolset, T. Henriksen, T. Lekva, T. Michelsen

Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case–control study

Y. Zhang, D. Dilimulati, D. Chen, M. Cai, H. You, H. Sun, X. Gao, X. Shao, M. Zhang, S. Qu

COVID-19 Original Article

Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients

D. T. W. Lui, C. H. Lee, W. S. Chow, A. C. H. Lee, A. R. Tam, C. Y. Y. Cheung, C. H. Y. Fong, S. T. M. Kwok, C. Y. Law, K. K. W. To, C. W. Lam, K. C. B. Tan, Y. C. Woo, I. F. N. Hung, K. S. L. Lam

COVID-19 Original Article

Vitamin D and interferon-γ co-operate to increase the ACE-2 receptor expression in primary cultures of human thyroid cells

F. Coperchini, A. Greco, M. Denegri, F. A. Ripepi, B. Grillini, J. Bertini, B. Calì, L. Villani, F. Magri, L. Croce, C. Gaetano, C. Cappelli, P. Trimboli, L. Chiovato, M. Rotondi

Hypogonadism Original Article

MKRN3 circulating levels in Prader–Willi syndrome: a pilot study

M. Mariani, D. Fintini, G. Cirillo, S. Palumbo, E. M. del Giudice, S. Bocchini, M. Manco, M. Cappa, A. Grandone

Open Access Diplopia Original Article

Sirolimus as a second-line treatment for Graves’ orbitopathy

G. Lanzolla, M. N. Maglionico, S. Comi, F. Menconi, P. Piaggi, C. Posarelli, M. Figus, C. Marcocci, M. Marinò

Insulins Original Article

Stachydrine alleviates lipid-induced skeletal muscle insulin resistance via AMPK/HO-1-mediated suppression of inflammation and endoplasmic reticulum stress

T. W. Jung, H. Kim, S. Y. Park, W. Cho, H. Oh, H. J. Lee, A. M. Abd El-Aty, A. Hacimuftuoglu, J. H. Jeong

Open Access Metastasis Original Article

Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study

R. Modica, C. Scandurra, N. M. Maldonato, P. Dolce, G. G. Dipietrangelo, R. Centello, V. Di Vito, E. Giannetta, A. M. Isidori, A. Lenzi, A. Faggiano, A. Colao

Letter

A case report of PTH elevation due to immunoassay interference

V. Calabrò, S. Lovriha, L. Zandonà, F. Sirianni, B. Fabris, S. Bernardi

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine